Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Mass cytometry nanotools for intracellular target engagement. Towards precision medicine.

Project description

Mass cytometry nanotools for intracellular protein targeting

The discovery of multi-kinase inhibitors has emerged as a strong novel treatment for many human cancers. However, the severe side effects due to their intrinsic off-target action impose restrictions on their dosage and limit their efficacy. The EU-funded TARGETOF project proposes an efficient approach to detect the binding of a given drug to intracellular target proteins. The approach combines intracellular target engagement devices based on nanotechnology with state-of-the-art mass cytometry techniques, allowing one-step target engagement profiling, thus streamlining the discovery of the action profile of a given drug. This research will greatly contribute to the development of straightforward methods to detect the most expressed targets in the biopsies and select the best course of treatment for the patient.

Objective

Cancer is the second highest cause of death in Europe and one of the biggest challenges facing humanity. The discovery of multi-kinase inhibitors has emerged as a strong alternative treatment for many cancers. However, the appearance of severe side effects due to their intrinsic target promiscuity limits the dosage and efficiency of these treatments. Therefore the characterisation of this promiscuity is crucial to develop selective and safe treatments. We propose a versatile and efficient approach to detect the binding of a given drug to target proteins. Combining intracellular target engagement devices based on nanotechnology with the state-of-the-art mass cytometry techniques, this approach will allow one-step target engagement profiling, and thus will streamline the discovery of the mode-of-action of a given drug. Furthermore, the development of an intracellular barcoding system in combination with the multiplexing capacities of mass cytometry will allow for the combination of multiple cell types in one single experiment, further accelerating the target deconvolution process. This research will greatly contribute to the development of a straightforward method to detect the most expressed targets in patient biopsies, and to select the best therapy for a given patient. This fellowship will consolidate me as an independent researcher, providing me with the opportunity for many cross-disciplinary collaborations, and to establish myself as an expert in the field of precision medicine.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-IF-2019

See all projects funded under this call

Coordinator

UNIVERSIDAD DE GRANADA
Net EU contribution
€ 160 932,48
Address
CUESTA DEL HOSPICIO SN
18071 Granada
Spain
Region
Sur Andalucía Granada
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 160 932,48